17312-165 NDC - EYE LID RELIEF (EPINEPHRINE, SILVER. CALCIUM SULFATE ANHYDROUS, CLEMATIS RECTA, EUPHRASIA STRICTA, GRAPHITE, GOLDENSEAL, PULSATILLA PULSATILLA VULGARIS)

Drug Information

Product NDC: 17312-165

Proprietary Name: Eye Lid Relief

Non Proprietary Name: EPINEPHRINE, SILVER. CALCIUM SULFATE ANHYDROUS, CLEMATIS RECTA, EUPHRASIA STRICTA, GRAPHITE, GOLDENSEAL, PULSATILLA PULSATILLA VULGARIS

Active Ingredient(s):
  • 6 [hp_X]/g GOLDENSEAL;
  • 6 [hp_X]/g EUPHRASIA STRICTA;
  • 9 [hp_X]/g CALCIUM SULFATE ANHYDROUS;
  • 11 [hp_X]/g SILVER;
  • 6 [hp_X]/g PULSATILLA VULGARIS;
  • 11 [hp_X]/g GRAPHITE;
  • 6 [hp_X]/g CLEMATIS RECTA FLOWERING TOP;
  • 7 [hp_X]/g EPINEPHRINE


Administration Route(s): TOPICAL

Dosage Form(s): OINTMENT

Labeler Information

Labeler Name: TRP Company
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:5/28/2018

Package Information

No. Package Code Package Description Billing Unit
117312-165-131 TUBE in 1 PACKAGE (17312-165-13) > 4 g in 1 TUBE

NDC Record

Field Name Field Value Definition
PRODUCT NDC17312-165The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEEye Lid ReliefThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEEPINEPHRINE, SILVER. CALCIUM SULFATE ANHYDROUS, CLEMATIS RECTA, EUPHRASIA STRICTA, GRAPHITE, GOLDENSEAL, PULSATILLA PULSATILLA VULGARISThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMEOINTMENTThe translation of the dosage form Code submitted by the firm.
ROUTE NAMETOPICALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE5/28/2018This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMETRP CompanyName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEGOLDENSEAL; EUPHRASIA STRICTA; CALCIUM SULFATE ANHYDROUS; SILVER; PULSATILLA VULGARIS; GRAPHITE; CLEMATIS RECTA FLOWERING TOP; EPINEPHRINEThis is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH6; 6; 9; 11; 6; 11; 6; 7 
ACTIVE INGRED UNIT[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/19/2021